Literature DB >> 30701309

Lack of β-amyloid cleaving enzyme-1 (BACE1) impairs long-term synaptic plasticity but enhances granule cell excitability and oscillatory activity in the dentate gyrus in vivo.

Matej Vnencak1,2, Marieke L Schölvinck3, Stephan W Schwarzacher4, Thomas Deller4, Michael Willem5, Peter Jedlicka6,7.   

Abstract

BACE1 is a β-secretase involved in the cleavage of amyloid precursor protein and the pathogenesis of Alzheimer's disease (AD). The entorhinal cortex and the dentate gyrus are important for learning and memory, which are affected in the early stages of AD. Since BACE1 is a potential target for AD therapy, it is crucial to understand its physiological role in these brain regions. Here, we examined the function of BACE1 in the dentate gyrus. We show that loss of BACE1 in the dentate gyrus leads to increased granule cell excitability, indicated by enhanced efficiency of synaptic potentials to generate granule cell spikes. The increase in granule cell excitability was accompanied by prolonged paired-pulse inhibition, altered network gamma oscillations, and impaired synaptic plasticity at entorhinal-dentate synapses of the perforant path. In summary, this is the first detailed electrophysiological study of BACE1 deletion at the network level in vivo. The results suggest that BACE1 is important for normal dentate gyrus network function. This has implications for the use of BACE1 inhibitors as therapeutics for AD therapy, since BACE1 inhibition could similarly disrupt synaptic plasticity and excitability in the entorhinal-dentate circuitry.

Entities:  

Keywords:  Alzheimer’s disease; Electrophysiology; LTP; Local field potentials (LFPs); Population spike

Mesh:

Substances:

Year:  2019        PMID: 30701309     DOI: 10.1007/s00429-019-01836-6

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  4 in total

1.  Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance.

Authors:  Neeraj Singh; Brati Das; John Zhou; Xiangyou Hu; Riqiang Yan
Journal:  Sci Adv       Date:  2022-07-20       Impact factor: 14.957

Review 2.  Amyloid, APP, and Electrical Activity of the Brain.

Authors:  Dimitri Hefter; Susann Ludewig; Andreas Draguhn; Martin Korte
Journal:  Neuroscientist       Date:  2019-11-29       Impact factor: 7.519

3.  Novel multifunctional iron chelators of the aroyl nicotinoyl hydrazone class that markedly enhance cellular NAD+ /NADH ratios.

Authors:  Zhixuan Wu; Duraippandi Palanimuthu; Nady Braidy; Nor Hawani Salikin; Suhelen Egan; Michael L H Huang; Des R Richardson
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

4.  Aη-α and Aη-β peptides impair LTP ex vivo within the low nanomolar range and impact neuronal activity in vivo.

Authors:  Jade Dunot; Sandy M Yishan; Maria Mensch; Samuel S Harris; Aline Blistein; Alban Avdiu; Paula A Pousinha; Camilla Giudici; Marc Aurel Busche; Peter Jedlicka; Michael Willem; Hélène Marie
Journal:  Alzheimers Res Ther       Date:  2021-07-08       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.